BP000134-GD21: Recombinant Human Interleukin-11 (IL-11) Protein
Source: P. Pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine 7TD1 was found to be less than 0.2 ng/ml, corresponding to a Specific Activity of 8.0 x 10^6 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000175-GD18: Recombinant Human Pegylated Granulocyte colony-stimulating factor (PEG-G-CSF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of murine NFS-60 indicator cells is < 0.1 ng/ml, corresponding to a specific activity of 6.0x10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.01 ng/ug (0.1 IEU/ug).BP000083-GD25: Recombinant Human IFNα 2b Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000176-GD19: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.01 ng/ug (0.1 IEU/ug).BP000145-GD20: Recombinant Human Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 10^7 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000083-GD26: Recombinant Human IFNα 2b Pegylated
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^6 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000123-GD22: Recombinant Human Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.03 ng/ml. Specific Activity of 3.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000997-GD23: Recombinant Human Beta-Nerve Growth Factor (β-NGF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells was less than1.0 ng/ml. Corresponding to a specific activity of > 1 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000082-GD27: Recombinant Human IFN alpha 2a (IFNA2) Protein
Source: E. coli-derived.
The specific activity as determined by a viral resistance assay using VSV-WISH cells was found to be 1.0 x 10^8 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000087-GD24: Recombinant Human Interferon-gamma (IFNγ) Protein
Source: E. coli-derived.
The specific activity as determined in a viral resistance assay using VSV-WISH cells was found to be greater than 1.5 x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).